FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2999779407> ?p ?o ?g. }

• W2999779407 endingPage "255" @default.
• W2999779407 startingPage "242" @default.
• W2999779407 abstract "BACKGROUND: Peritoneal metastases arise in patients with a variety of primary cancers, and are associated with a poor prognosis. Systemic chemotherapy is the mainstay of treatment; however, the morbidity is considerable and the survival benefit is modest. Cytoreductive surgery and heated intraperitoneal chemotherapy is a potentially curative treatment available to a minority of patients; however, most develop recurrent disease. A novel palliative treatment for peritoneal metastases, pressurized intraperitoneal aerosol chemotherapy, has recently been introduced. Pressurized intraperitoneal aerosol chemotherapy utilizes an aerosol of chemotherapy in carbon dioxide gas. It is instilled into the abdomen under pressure via laparoscopic ports. No cytoreduction is performed. Pressurized intraperitoneal aerosol chemotherapy can be repeated at 6-week intervals. Oxaliplatin or cis-platinum and doxorubicin have been used to date. OBJECTIVE: This study aims to systematically review and evaluate the method, and the preclinical and early clinical results of pressurized intraperitoneal aerosol chemotherapy. DATA SOURCES: Medline and the Cochrane Library were the data sources for the study. STUDY SELECTION: Peer-reviewed series of greater than 10 patients, with sufficient patient data, through April 2019, were selected. INTERVENTION: Patients with peritoneal metastases underwent pressurized intraperitoneal aerosol chemotherapy. MAIN OUTCOME MEASURES: Patient dropout, histologic tumor response, adverse events, and 30-day mortality were the primary outcomes measured. RESULTS: A total of 921 patients with peritoneal metastases were brought to the operating room for pressurized intraperitoneal aerosol chemotherapy. The number of pressurized intraperitoneal aerosol chemotherapy treatments administered was as follows: 1 treatment, 862 (94%); 2 treatments, 645 (70%); and 3 treatments, 390 patients (42%). Initial laparoscopic access was not possible in 59 patients (6.4%). Common Terminology Criteria for Adverse Events grade 3 or higher were noted in 13.7% of the patients who, collectively, underwent a total of 2116 treatments. The 30-day mortality was 2.4% (22/921). LIMITATIONS: This study was limited by the heterogeneity of reported data and primary tumor types and by the lack of long-term survival data. CONCLUSIONS: Early clinical results are encouraging, but tumor-specific, prospective, randomized trials are needed to compare pressurized intraperitoneal aerosol chemotherapy to systemic chemotherapy. This method has yet to be introduced to the United States. It is another therapeutic option for patients with peritoneal metastases and will broaden the patient base for future clinical trials." @default.
• W2999779407 created "2020-01-23" @default.
• W2999779407 creator A5004845960 @default.
• W2999779407 creator A5005824918 @default.
• W2999779407 creator A5008345745 @default.
• W2999779407 creator A5031484745 @default.
• W2999779407 creator A5057451917 @default.
• W2999779407 creator A5063141243 @default.
• W2999779407 creator A5086023168 @default.
• W2999779407 date "2020-02-01" @default.
• W2999779407 modified "2023-10-14" @default.
• W2999779407 title "Pressurized Intraperitoneal Aerosol Chemotherapy, a Palliative Treatment Approach for Patients With Peritoneal Carcinomatosis: Description of Method and Systematic Review of Literature" @default.
• W2999779407 cites W1563590460 @default.
• W2999779407 cites W1831381284 @default.
• W2999779407 cites W1853593785 @default.
• W2999779407 cites W1976360640 @default.
• W2999779407 cites W1980661013 @default.
• W2999779407 cites W1994039819 @default.
• W2999779407 cites W2022490736 @default.
• W2999779407 cites W2029469088 @default.
• W2999779407 cites W2051099595 @default.
• W2999779407 cites W2058231119 @default.
• W2999779407 cites W2060590865 @default.
• W2999779407 cites W2063098268 @default.
• W2999779407 cites W2080853165 @default.
• W2999779407 cites W2087230876 @default.
• W2999779407 cites W2094561096 @default.
• W2999779407 cites W2114335746 @default.
• W2999779407 cites W2117190139 @default.
• W2999779407 cites W2118548073 @default.
• W2999779407 cites W2119163457 @default.
• W2999779407 cites W2123458589 @default.
• W2999779407 cites W2133768270 @default.
• W2999779407 cites W2151456396 @default.
• W2999779407 cites W2161579588 @default.
• W2999779407 cites W2162553170 @default.
• W2999779407 cites W2170008162 @default.
• W2999779407 cites W2194281569 @default.
• W2999779407 cites W2271625988 @default.
• W2999779407 cites W2344894825 @default.
• W2999779407 cites W2415137199 @default.
• W2999779407 cites W2509109636 @default.
• W2999779407 cites W2509964897 @default.
• W2999779407 cites W2516882085 @default.
• W2999779407 cites W2521892896 @default.
• W2999779407 cites W2524247262 @default.
• W2999779407 cites W2556306852 @default.
• W2999779407 cites W2567965265 @default.
• W2999779407 cites W2587647864 @default.
• W2999779407 cites W2590370975 @default.
• W2999779407 cites W2591361541 @default.
• W2999779407 cites W2605936377 @default.
• W2999779407 cites W2615552839 @default.
• W2999779407 cites W2626642242 @default.
• W2999779407 cites W2660828425 @default.
• W2999779407 cites W2745873080 @default.
• W2999779407 cites W2760472470 @default.
• W2999779407 cites W2766777872 @default.
• W2999779407 cites W2770923658 @default.
• W2999779407 cites W2777253173 @default.
• W2999779407 cites W2782706869 @default.
• W2999779407 cites W2791527878 @default.
• W2999779407 cites W2803539671 @default.
• W2999779407 cites W2805943215 @default.
• W2999779407 cites W2806804067 @default.
• W2999779407 cites W2808343462 @default.
• W2999779407 cites W2885546665 @default.
• W2999779407 cites W2898330049 @default.
• W2999779407 cites W2902772726 @default.
• W2999779407 cites W2908569721 @default.
• W2999779407 cites W2913085481 @default.
• W2999779407 cites W2946079442 @default.
• W2999779407 cites W4294215472 @default.
• W2999779407 doi "https://doi.org/10.1097/dcr.0000000000001565" @default.
• W2999779407 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31914116" @default.
• W2999779407 hasPublicationYear "2020" @default.
• W2999779407 type Work @default.
• W2999779407 sameAs 2999779407 @default.
• W2999779407 citedByCount "10" @default.
• W2999779407 countsByYear W29997794072020 @default.
• W2999779407 countsByYear W29997794072021 @default.
• W2999779407 countsByYear W29997794072022 @default.
• W2999779407 countsByYear W29997794072023 @default.
• W2999779407 crossrefType "journal-article" @default.
• W2999779407 hasAuthorship W2999779407A5004845960 @default.
• W2999779407 hasAuthorship W2999779407A5005824918 @default.
• W2999779407 hasAuthorship W2999779407A5008345745 @default.
• W2999779407 hasAuthorship W2999779407A5031484745 @default.
• W2999779407 hasAuthorship W2999779407A5057451917 @default.
• W2999779407 hasAuthorship W2999779407A5063141243 @default.
• W2999779407 hasAuthorship W2999779407A5086023168 @default.
• W2999779407 hasConcept C121608353 @default.
• W2999779407 hasConcept C126322002 @default.
• W2999779407 hasConcept C141071460 @default.
• W2999779407 hasConcept C2776694085 @default.
• W2999779407 hasConcept C2777506904 @default.
• W2999779407 hasConcept C2778239845 @default.
• W2999779407 hasConcept C2779458272 @default.

• next